A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure

Trial Identifier: D7960C00009
Sponsor: AstraZeneca
Collaborator:
Fortrea
Start Date: October 2024
Primary Completion Date: April 2025
Study Completion Date: May 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, CA Inglewood, CA, US, 90301
US, CA Northridge, CA, US, 91325
US, CA Pomona, CA, US, 91767
US, FL Boca Raton, FL, US, 33434
US, FL Hialeah, FL, US, 33012
US, FL Jacksonville, FL, US, 32216
US, FL Miami, FL, US, 33165
US, FL Miami, FL, US, 33122
US, FL Miami, FL, US, 33174
US, FL Miami, FL, US, 33173
US, FL Ocala, FL, US, 34474
US, FL Port Orange, FL, US, 32127
US, FL Tamarac, FL, US, 33321
US, IL Chicago, IL, US, 60621
US, MA New Bedford, MA, US, 02740
US, MD Potomac, MD, US, 20854
US, NY New Windsor, NY, US, 12553
US, OH Beavercreek, OH, US, 45431
US, PA Horsham, PA, US, 19044
US, SC Spartanburg, SC, US, 29303
US, TX Austin, TX, US, 78704
US, TX Dallas, TX, US, 75230
US, TX El Paso, TX, US, 79905
US, TX Hurst, TX, US, 76054
US, TX Mesquite, TX, US, 75149
US, TX Paris, TX, US, 75462